Mechanisms of disease: Production and actions of estrogens

New England Journal of Medicine

Volumn 346, Issue 5, 2002, Pages 340-352

  Gruber, Christian J ^a   Tschugguel, Walter ^a   Schneeberger, Christian ^a   Huber, Johannes C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; DAIDZEIN; ENTEROLACTONE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; GENISTEIN; TESTOSTERONE; ESTROGEN RECEPTOR; ISOFLAVONE DERIVATIVE; LIGAND; PHYTOESTROGEN; PLANT MEDICINAL PRODUCT; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ESTROGEN RESPONSIVE ELEMENT; HORMONE ACTION; HORMONE METABOLISM; HORMONE STRUCTURE; HORMONE TRANSPORT; HUMAN; PRIORITY JOURNAL; REVIEW; BLOOD VESSEL; BONE; BREAST; CENTRAL NERVOUS SYSTEM; CHEMISTRY; FEMALE; METABOLISM; PHYSIOLOGY;

BLOOD VESSELS; BONE AND BONES; BREAST; CENTRAL NERVOUS SYSTEM; ESTROGENS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; LIGANDS; PHYTOESTROGENS; PLANT PREPARATIONS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0037204192     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra000471     Document Type: Review

References (102)

1. Sterol carrier protein 2 and fatty acid-binding protein: Separate and distinct physiological functions
2. Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein
3. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia
4. Dietary phytoestrogens and cancer: In vitro and in vivo studies
5. Genistein, a specific inhibitor of tyrosine-specific protein kinases
6. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein
7. Phyto-oestrogens: Where are we now?
8. Follicular oestrogen synthesis: The "two-cell, two-gonadotrophin" model revisited
9. Are estradiol-producing cells incompletely endowed? A chronicle of the emergence of certitude from conjecture
10. Aromatization by skeletal muscle
11. Aromatase activity in breast tissue
12. The formation of estrogens by central neuroendocrine tissues
13. Aromatase in the human testis
14. Placental estrogen biosynthesis during human pregnancy
15. Twenty-four-hour concentration profiles of gonadotropin and estradiol (E2) in prepubertal and early pubertal girls: The diurnal rise of E2 is opposite the nocturnal rise of gonadotropin
16. Blood production and ovarian secretion rates of estradiol-17β and estrone in women throughout the menstrual cycle
17. The metabolic clearance and blood production rates of estriol in normal, non-pregnant women
18. Hormonal control of gene expression in the ovary
19. Insulin-like growth factors: The ovarian connection
20. Intrafollicular paracrine function of ovarian androgen
21. Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
22. Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy
23. Sex-hormone-binding globulin
24. Multiple functions of aromatase and the active site structure: Aromatase is the placental estrogen 2-hydroxylase
25. Tissue specificity: The clinical importance of steroid metabolites in hormone replacement therapy
26. Is estradiol a genotoxic mutagenic carcinogen?
27. Biological esterification of steroids
28. Association of estrogens with human plasma lipoproteins: Studies using estradiol-17beta and its hydrophobic derivative
29. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol: Requirement for estradiol modification
30. Steroid receptors and their associated proteins
31. Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α
32. Caveolin-1 potentiates estrogen receptor α (ERα) signaling: Caveolin-1 drives ligand-independent nuclear translocation and activation of ERα
33. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
34. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor
35. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
36. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
37. Characterization of bacterially expressed rat estrogen receptor β ligand binding domain by mass spectrometry: Structural comparison with estrogen receptor α
38. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
39. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
40. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern
41. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
42. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
43. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice
44. Generation and reproductive phenotypes of mice lacking estrogen receptor beta
45. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β
46. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
47. Molecular basis of agonism and antagonism in the oestrogen receptor
48. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
49. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
50. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
51. Role of CBP/P300 in nuclear receptor signalling
52. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens
53. Tamoxifen resistant breast cancer: Coregulators determine the direction of transcription by antagonist-occupied steroid receptors
54. Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes
55. L expression and β-amyloid-induced apoptosis: Relevance to Alzheimer's disease
56. Sequence requirements for estrogen receptor binding to estrogen response elements
57. Estrogen induction of TGF-alpha is mediated by an estrogen response element composed of two imperfect palindromes
58. Steroid hormone receptors and their regulation by phosphorylation
59. Modulating nuclear receptor function: May the phos be with you
60. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone
61. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element
62. The unliganded estrogen receptor (ER) transduces growth factor signals
63. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells
64. Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors
65. Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor
66. 3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α
67. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae
68. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor
69. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription
70. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
71. Estrogen hits the surface
72. Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women
73. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women
74. Treatment of skin aging with topical estrogens
75. Hormone replacement therapy and intraocular pressure
76. Hormonal regulation of breast development and activity
77. Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle
78. Aromatase within the breast
79. Brain aromatization of androgens
80. Novel mechanisms of estrogen action in the brain: New players in an old story
81. Estrogen effects on the synaptology and neural membranes of the rat hypothalamic arcuate nucleus
82. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair
83. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density
84. 17 Alpha-estradiol exerts neuroprotective effects on SK-N-SH cells
85. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides
86. The epidemiology of estrogen replacement therapy in Alzheimer's disease
87. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial: Alzheimer's Disease Cooperative Study
88. Human vascular smooth muscle cells contain functional estrogen receptor
89. Identification of authentic estrogen receptor in cultured endothelial cells: A potential mechanism for steroid hormone regulation of endothelial function
90. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism
91. Hormone replacement therapy and coronary artery atherosclerosis: The monkey model
92. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis: Estradiol as a survival factor
93. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model
94. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
95. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
96. Avian osteoclasts as estrogen target cells
97. Evidence of estrogen receptors in normal human osteoblast-like cells
98. Cytokines, bone remodeling, and estrogen deficiency: A 1998 update
99. Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis
100. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy
101. Treatment of postmenopausal osteoporosis with transdermal estrogen
102. Prevention of spinal osteoporosis in oophorectomised women